VivoSim Labs

VIVSNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$7.845 M

$0.47 +41.86%

Close of 7 Aug 2026

Revenue

$131.0K

#3602 by revenue

Earnings

-$13.8M

Loss-making

Shares outstanding

3,494,071

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#149Creative Medical TechnologyCELZ$9.36M
#150AIM ImmunoTechAIM$7.91M
#151VivoSim LabsVIVS$7.85M
#152CurisCRIS$7.83M
#153Liminatus PharmaLIMN$6.92M

Where these numbers come from

Share counts and financials for VivoSim Labs are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.